Positive Preclinical Data for ALKS 4230 Presented at Society for Immunotherapy of Cancer (SITC) 32Business Wire (press release)Data presented by Dr. Brian Gastman of the Cleveland Clinic at the Society for Immunotherapy of Cancer (SITC) Annual Meeting … Continue reading
|
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology …
PR Newswire UK (press release) The virtual lab is a new collaboration between institutes undertaking world-leading research in biological measurements, which positions UK as a global leader in the industrialisation of synthetic biology: NPL, LGC, the UK’s National Measurement … |
|
Even if This ALS Stem Cell Experiment Fails, It’ll Be Considered a Success
Daily Beast “I think it’s a very exciting potential to explore, to see if excitability of nerve cells is one of the reasons causing the disease and therefore this drug might dampen that,” she said. “We can ask questions of those [stem cell] lines and use them for … |
STAT |
Revolutionary new cancer therapies come with big risks. Drug makers must be prepared
STAT These new drugs, the first in the new family of CAR–T cell therapies 3, could revolutionize the treatment of blood cancers and make inroads into the treatment of solid tumors. They work by isolating immune cells 4 known as T cells from a patient’s … Cellectis gets FDA go-ahead to restart fatal CAR–T trialpharmaphorum |